Advertisement

Product › Details
pain drug
![]() |
Next higher product group | analgesic / antirheumatic |
Status | 1998-01-01 sales existent | |
Record changed: 2021-03-28 |
Advertisement
![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
More documents for pain drug
- [1] Grünenthal GmbH. (4/12/21). "Press Release: Grünenthal Acquires Mestex AG and Its Phase-III-ready Investigational Medicine MTX-071 for the Treatment of Pain Associated with Osteoarthritis of the Knee". Aachen....
- [2] Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde....
- [3] AlgoTherapeutix S.A.S.. (11/24/20). "Press Release: AlgoTherapeutix Raises €12M to Take ATX01 into Clinical Development in Chemotherapy-induced Peripheral Neuropathy". Paris....
- [4] Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne....
- [5] Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane....
- [6] Grünenthal GmbH. (8/13/19). "Pressemitteilung: Einigung über Neuausrichtung der Forschungs- und Entwicklungsorganisation bei Grünenthal". Aachen....
- [7] Grünenthal GmbH. (5/8/19). "Press Release: Grünenthal to Strengthen Core Competencies in R&D". Aachen....
- [8] Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen....
- [9] Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel....
- [10] Iontas Ltd.. (5/30/18). "Press Release: Iontas Awarded £556K ($737K) from Innovate UK to Develop Therapies for Chronic Pain Management". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top